A detailed history of Cwm, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 22 shares of RNA stock, worth $782. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 8 175.0%
Holding current value
$782
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$37.21 - $48.14 $520 - $673
14 Added 175.0%
22 $1,000
Q2 2024

Jul 09, 2024

BUY
$22.73 - $40.85 $181 - $326
8 New
8 $0
Q3 2023

Oct 11, 2023

BUY
$6.3 - $11.35 $894 - $1,611
142 Added 191.89%
216 $1,000
Q2 2023

Aug 03, 2023

BUY
$10.62 - $17.34 $785 - $1,283
74 New
74 $1,000
Q2 2022

Jul 28, 2022

BUY
$11.18 - $20.5 $1,118 - $2,050
100 New
100 $1,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.85B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.